PHG
Koninklijke Philips N.V.
PHG has a slight edge over UNH overall, supported by stronger fundamentals.
UNH
UnitedHealth Group Incorporated
UNH has slightly lower modeled downside risk, despite its lower overall score.
PHG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Healthy |
PHG's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
PHG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7x | $9.06 | -70% |
| Current | 23x | $30.05 | — |
| Fair | 29x | $37.91 | +26% |
| Expensive | 40x | $51.41 | +71% |
Historical ranges are pointers, not guarantees.
PHG's PE is 23x, but its earnings don't support one, so it isn't a reliable read right now.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH has the edge over PHG in the historical PE scenario, which offers more potential upside but is not a forecast.
PHG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
PHG has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
PHG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.29 | +579% |
| Q1 2026 | $1.12 | +155% |
| Q4 2025 | $1.03 | +$1.90 |
| Q3 2025 | $0.18 | +$0.61 |
| Q2 2025 | $0.19 | +$0.73 |
| Q1 2025 | $0.44 | +$1.43 |
| Q1 2024 | -$0.99 | +$1.60 |
| Q1 2023 | -$2.59 | -171% |
PHG has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
PHG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +0.5% |
| Q1 2026 | $4.3B | -4.7% |
| Q4 2025 | $5.7B | +1.1% |
| Q3 2025 | $4.8B | -1.7% |
| Q2 2025 | $4.8B | -2.8% |
| Q1 2025 | $4.6B | -1% |
| Q4 2024 | $5.6B | -0.4% |
| Q3 2024 | $4.9B | -2.1% |
PHG's revenue fell from its 2020 peak and has held roughly level since: $4.8B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +4.8 points |
| Q1 2026 | 6.2% | +2.4 points |
| Q4 2025 | 11% | +6.6 points |
| Q3 2025 | 7.7% | 0 points |
| Q2 2025 | 9.2% | -9.1 points |
| Q1 2025 | 3.8% | +24 points |
| Q4 2024 | 4% | +3.5 points |
| Q3 2024 | 7.7% | +2.7 points |
PHG has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over PHG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
PHG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $243.3M | -3.9% |
| Q1 2026 | $129.9M | +$1.3B |
| Q4 2025 | $1.5B | +$1.5B |
| Q3 2025 | $287.7M | +$287.7M |
| Q2 2025 | $253.3M | +$331M |
| Q1 2025 | -$1.2B | -$776.3M |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
PHG's free cash flow is usually positive and has bounced back after one negative quarter: $2.1B over the past year, against −$902M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over PHG on cash flow, with more consistent year-over-year improvement.
PHG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +44K shares |
| 1 year | +1.2% | +11.9M shares |
| 3 years | +2.3% | +22M shares |
| 5 years | +1.3% | +12.3M shares |
| Available history | +0.6% | +6.2M shares |
PHG has 969M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $75.5M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
PHG spent $76M buying back its own shares over the past year, after none the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over PHG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
PHG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | 2.0x | Moderate |
| Q4 2025 | 2.0x | Moderate |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 6.2x | High |
| Q3 2024 | -1.5x | Net Cash |
PHG's net debt is about 1.9 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over PHG on leverage, with a lower net debt burden relative to earnings.
PHG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.3 | Neutral |
| Stochastic | 84.8 | Overbought |
PHG's weekly RSI is 64 (neutral) and its Stochastic is 85 (overbought).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
PHG PE vs Healthcare Sector
| Metric | PHG | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 9.8% below |
| PE % | 29 | 29 | Same percentile |
PHG is trading at 23x earnings, in line with the Healthcare sector's median of 26x, though its earnings don't support one.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over PHG on valuation relative to its sector.
PHG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.6 | 13% above |
| 20 week MA | $26.6 | 13% above |
| 50 week MA | $27.4 | 9.9% above |
| 100 week MA | $26.7 | 13% above |
| 200 week MA | $24.5 | 23% above |
PHG has the edge over UNH on trend strength, trading above more of its moving averages.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
PHG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.5 | $49.8 | +12% |
| 2021 | $49.8 | $33.6 | -33% |
| 2022 | $33.6 | $14.9 | -56% |
| 2023 | $14.9 | $22.6 | +51% |
| 2024 | $22.6 | $25.6 | +13% |
| 2025 | $25.6 | $27.1 | +6% |
| 2026 YTD | $27.1 | $30.1 | +11% |
PHG has finished higher in four of the last six years. It's up 11% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over PHG on returns for 2026, with the stronger performance.